UnknownPhase 4

Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.

Brazil240 participantsStarted 2021-02-01

Plain-language summary

The use of intrauterine device (IUD) in Brazil is still not very significant and one of the reasons is the fear of feeling pain during its insertion procedure. Articaine is an amide-linked local anesthetic, its plasma half-life is shorter than that of most other amide-type anesthetics, which makes it theoretically favorable in relation to systemic toxicity.

Who can participate

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Female patients, aged between 20 and 40 years Exclusion Criteria: * Diabetes (type I or II) * Chronic Kidney * Urogenital infections * Psychiatric disesas * Surgery during the study period

What they're measuring

Pain assessment

Timeframe: 15 minutes

Trial details

NCT IDNCT05252117

SponsorUniversidade do Vale do Sapucai

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-04-30

Contact for this trial

Thaise M Nery, Physician

+55 35 999664418 melo_nery@outlook.com

View on ClinicalTrials.gov More Contraception trials